跳到正文
原文
Endpoints News 生物医药· Ryan Cross·· 8 天前AI 评分15

Ira Mellman 对 Parker Institute 的癌症免疫疗法感到失望

Ira Mellman wants Parker Institute to restore cancer immunotherapy

AI 导读

Ira Mellman 对 Revolution Medicines 的新抗癌药物 daraxonrasib 表示失望,尽管全球对此药反响热烈。

正文

While the whole world was ap­plaud­ing Rev­o­lu­tion Med­i­cines’ new can­cer drug, all Ira Mell­man felt was dis­ap­point­ment and frus­tra­tion.

The pill, darax­on­ra­sib, kept pa­tients with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news